These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 902712)

  • 1. Correlation of pathology with distribution of Be following administration of beryllium sulfate and beryllium sulfosalicylate complexes to the rat.
    Hard GC; Skilleter DN; Reiner E
    Exp Mol Pathol; 1977 Oct; 27(2):197-212. PubMed ID: 902712
    [No Abstract]   [Full Text] [Related]  

  • 2. Acute inhalation toxicity of beryllium; the enhancing effect of the inhalation of hydrogen fluoride vapor on beryllium sulfate poisoning in animals.
    STOKINGER HE; ASHENBURG NJ; DeVOLDRE J; SCOTT JK; SMITH FA
    Arch Ind Hyg Occup Med; 1950 Apr; 1(4):398-410. PubMed ID: 15433489
    [No Abstract]   [Full Text] [Related]  

  • 3. EFFECTIVENESS OF AURIN TRICARBOXYLIC ACID (ATA) AS AN ANTIDOTE FOR BERYLLIUM POISONING.
    KING ME; SHEFNER AM; EHRLICH R
    Ind Med Surg; 1964 Aug; 33():566-9. PubMed ID: 14196998
    [No Abstract]   [Full Text] [Related]  

  • 4. Salicylates and experimental beryllium poisoning.
    FINKEL AJ; WHITE MR
    Proc Soc Exp Biol Med; 1952 Apr; 79(4):672-3. PubMed ID: 14920531
    [No Abstract]   [Full Text] [Related]  

  • 5. The uptake and subsequent loss of beryllium by rat liver parenchymal and non-parenchymal cells after the intravenous administration of particulate and soluble forms.
    Skilleter DN; Price RJ
    Chem Biol Interact; 1978 Mar; 20(3):383-96. PubMed ID: 657398
    [No Abstract]   [Full Text] [Related]  

  • 6. [Beryllium poisoning and the effects of percutaneous administration of salicylates].
    MAEHDER K
    Med Monatsschr; 1955 Apr; 9(4):249-50. PubMed ID: 14393502
    [No Abstract]   [Full Text] [Related]  

  • 7. Studies on the mechanism of protection by aurintricarboxylic acid in beryllium poisoning. II. Equilibria involving alkaline phosphatase.
    SCHUBERT J; LINDENBAUM A
    J Biol Chem; 1954 May; 208(1):359-68. PubMed ID: 13174545
    [No Abstract]   [Full Text] [Related]  

  • 8. Hygienic and toxicological aspects of occupational and environmental exposure to beryllium.
    Bencko V; Vasil'eva EV
    J Hyg Epidemiol Microbiol Immunol; 1983; 27(4):403-17. PubMed ID: 6663073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New insight in beryllium toxicity excluding exposure to beryllium-containing dust: accumulation patterns, target organs, and elimination.
    Drobyshev E; Kybarskaya L; Dagaev S; Solovyev N
    Arch Toxicol; 2019 Apr; 93(4):859-869. PubMed ID: 30891623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pathological anatomy of acute experimental beryllium poisoning and peripheral blood changes resulting from intravenous administration of beryllium sulphate.
    SCOTT JK
    At Energy Biophys Biol Med; 1948 Aug; 1(5):183. PubMed ID: 18878768
    [No Abstract]   [Full Text] [Related]  

  • 11. [Cardiovascular effects of beryllium sulfate poisoning].
    Caujolle F; Chanh PH; Maciotta-Lapoujade M; Silve-Mamy G
    Agressologie; 1968; 9(4):531-6. PubMed ID: 5722620
    [No Abstract]   [Full Text] [Related]  

  • 12. Mobilization and distribution of beryllium over the course of chelation therapy with some polyaminocarboxylic acids in the rat.
    Mathur S; Flora SJ; Mathur R; Das Gupta S
    Hum Exp Toxicol; 1993 Jan; 12(1):19-24. PubMed ID: 8094965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of phosphoorganic complexons on the activity of alkaline phosphatase in beryllium poisoning].
    Arkhipova OG; Demokidova NK
    Farmakol Toksikol; 1967; 30(3):352-6. PubMed ID: 4970461
    [No Abstract]   [Full Text] [Related]  

  • 14. [Metabolic kinetics, distribution and elimination of beryllium from the body].
    Zhuravlve VF; Bugryshev PF
    Gig Sanit; 1974 Oct; (10):74-7. PubMed ID: 4618827
    [No Abstract]   [Full Text] [Related]  

  • 15. The intravenous use of ethylenediamine tetraacetic acid in the treatment of pulmonary berylliosis. A case report.
    MATZEN RN; WINSTON RB
    Guthrie Clin Bull; 1960; 29():109-17. PubMed ID: 13768361
    [No Abstract]   [Full Text] [Related]  

  • 16. [Oxidation processes in the lungs of rats following poisoning by beryllium compounds].
    Karamzina NM; Pavlova IV
    Gig Tr Prof Zabol; 1966 Sep; 16(9):32-6. PubMed ID: 6001338
    [No Abstract]   [Full Text] [Related]  

  • 17. [Distribution of beryllium in the organs of rats].
    Bugryshev PF; Moskalev IuI; Kuznetsov AA; Nazarova VA
    Farmakol Toksikol; 1976; 39(5):615-8. PubMed ID: 1028592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improvement of pulmonary function following the administration of adrenocorticotrophic hormone (ACTH) in chronic beryllium poisoning.
    INKLEY SR; KLINE EM; PRITCHARD WH
    J Lab Clin Med; 1950 Nov; 36(5):840-1. PubMed ID: 14784716
    [No Abstract]   [Full Text] [Related]  

  • 19. [Accelerated excretion of beryllium with phosphicin].
    Arkhipova OG; Medved' TIa; Rudomino MV; Kabachnik MI
    Gig Tr Prof Zabol; 1967 Mar; 11(3):19-23. PubMed ID: 5615694
    [No Abstract]   [Full Text] [Related]  

  • 20. Beryllium binding to HLA-DP molecule carrying the marker of susceptibility to berylliosis glutamate beta 69.
    Amicosante M; Sanarico N; Berretta F; Arroyo J; Lombardi G; Lechler R; Colizzi V; Saltini C
    Hum Immunol; 2001 Jul; 62(7):686-93. PubMed ID: 11423174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.